Entries by Hanne

Oscare Medical exhibits OsCare Sono® in the World Congress on Osteoporosis in Málaga

Oscare Medical will exhibit its unique low frequency ultrasound device for osteoporosis assessment, OsCare Sono®, at this year’s World Congress on Osteoporosis, Osteoarthritis and Musculosceletal Diseases. The WCO-IOF-ESCEO congress will take place in Málaga, Spain, from April 14th to 17th. With over 3,200 participants, it is the largest educational event and most vibrant clinical research […]

Oscare Medical showcases its unique osteoporosis screening device in Arab Health 2016 together with distributor Z1 International

VANTAA, Finland — Oscare Medical announces that it will exhibit its unique low frequency ultrasound device, the OsCare Sono®, for osteoporosis assessment at this year’s Arab Health, together with its distributor in Middle East, Z1 International. Arab Health is Middle East’s largest medical exhibition and will be held on 25th – 28th January in Dubai, […]

Meditek appointed Oscare Medical’s distributor in Norway and Sweden

VANTAA, Finland – Oscare Medical announces that Meditek has been appointed as its distributor for the OsCare Sono® device for osteoporosis risk assessment in Norway and Sweden. Meditek, established in 1992, is a medical technology distributor focused on lung medicine on one hand and endoscopy and ultrasound on the other. The company has been a […]

Oscare Medical showcases novel ultrasound device for assessment of osteoporosis at Medica 2015

Promises to make screening for risk of osteoporosis simple, reliable and affordable VANTAA, Finland – Oscare Medical Oy announces that it will be demonstrating its unique low frequency ultrasound device, the OsCare Sono® for osteoporosis assessment, at this year’s Medica in Hall 16, booth E57. Medica, the world’s largest medical exhibition, will be held on […]

Oscare Medical collaborates in Clinical Study with Geneva University Hospital

Oscare Medical has signed a Clinical Study Agreement with Geneva University Hospital (HUG) on the study titled “Low-frequency axial ultrasound velocity in elderly men and women from the Geneva Retirees Cohort: correlations with cortical thickness and porosity assessed by high-resolution peripheral quantitative computed tomography and associations with fracture history”. The research is conducted in the […]

Espansione to distribute OsCare Sono™ in Italy

VANTAA, Finland — Oscare Medical Oy announces that the Espansione Marketing SPA, part of the Bologna-based Espansione Group, is now distributing the OsCare Sono™ for osteoporosis assessment. Espansione is an established manufacturer and marketer of medical equipment with a special focus on the pharmacy market as a distribution channel in Italy. Life expectancy in Italy […]

New distributor for Oscare Medical in Poland

VANTAA, Finland — Oscare Medical Oy announces that Forel Medical, a Warsaw-based distributor of advanced medical technologies is now distributing the OsCare Sono™ for osteoporosis assessment. Forel Medical will be adding the OsCare Sono™ to the range of products they are already promoting to customers in markets such as gynecology and private clinics. Wojciech Borkowski, […]

Oscare to exhibit ultrasound-based method for osteoporosis assessment at Arab Health together with new distributor

Z1 International to distribute OsCare Sono™ in the Middle East VANTAA, Finland — Oscare Medical Oy announces that it will be demonstrating its novel low frequency ultrasound device, the OsCare Sono™ for osteoporosis assessment, at this year’s Arab Health together with Z1 International, at stand Z4T01. Arab Health is the region’s largest medical exhibition and […]

Oscare showcases its unique method for assessment of osteoporosis at Medica

Usefulness of OsCare Sono™ for assessment of osteoporosis validated in clinical studies VANTAA, Finland – Oscare Medical Oy announces that it will be demonstrating its novel low frequency ultrasound device, the OsCare Sono™ for osteoporosis assessment, at this year’s Medica in Hall 16, booth E57. Medica, the world’s largest medical exhibition, will be held on […]

OsCare Sono™ validated for osteoporosis screening in clinical studies

Two studies comparing the OsCare Sono™ measurement to central DXA measurements have recently been finalized. Given that central DXA measurement is considered the gold standard for diagnosis of osteoporosis, it is instructive to examine the association between OsCare Sono™ and DXA measurements and to determine the criteria needed to interpret OsCare Sono™ results. In a […]